Details for 2018166225
Up to date per 02.04.2026
Actions
Details for 2018166225
Granted/Registered
European Patent
28.11.2018 A
29.11.2023 B1
03.05.2011
US
201161482171 P
A61K 31/4965 20060101AFI20181020BHEP
Owner
Agios Pharmaceuticals, Inc.88 Sidney Street Cambridge, MA 02139US
Representative
Representative
Dipl.-Ing. Dr. techn. Elisabeth SchoberFlorianigasse 26/21080 WienAT
Inventor
SU, Shin-San Michael128 Beacon Street, Unit F Boston, MA 02116US
DANG, Lenny30 Union Park Street, No 201 Boston, MA 02118US
Information about Fees